Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the ACCME to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Ipsen Biopharmaceuticals, Inc.

Oncology Briefings™: Integrating Novel Targeted Treatment Strategies to Advance Pancreatic Cancer Care

Release Date: November 30, 2017
Expiration Date: November 30, 2018
Media: Internet - based


Activity Overview

Oncology Briefings™ is an online interactive monograph and print supplement that includes an overview of novel chemotherapeutic and targeted therapies for the treatment of patients with metastatic pancreatic cancer. Discussion includes pharmacodynamic and pharmacokinetic rationales behind novel treatment strategies, clinical data leading to new approvals, and treatment-related adverse events to monitor. A national thought leader interprets presented data, and provides key take-home points and clinical pearls for practice to place the content into clear perspective. Audio sidebars and tables provide supporting evidence for this activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Ipsen Biopharmaceuticals, Inc.

CME Activity Table of Contents

  • Introduction
  • Novel Chemotherapy Strategies
  • Other Targeted Therapies
  • Conclusion

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, "Educational Content/Audio Files" will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational initiative is directed toward medical oncologists, endocrinologists, radiation oncologists, and surgeons who treat patients with pancreatic cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of pancreatic cancer are also invited to participate.

Learning Objectives

Upon completion of this activity, you should be better able to:

  • Describe pharmacodynamic and pharmacokinetic approaches to the management of advanced forms of pancreatic cancer
  • Report clinical trial evidence on the efficacy of liposomal irinotecan and other novel treatments for the management of metastatic pancreatic cancer
  • Place clinical trial findings on novel targeted approaches into the context of evolving treatment paradigms in the field of advanced pancreatic cancer management
  • Detail differential toxicity profiles and approaches in multiple lines of therapy to mitigate the impact of treatment-related adverse events in the care of patients with metastatic pancreatic cancer

Faculty, Staff, and Planners' Disclosures


Tanios Bekaii-Saab , MD FACP
Program Co-Leader, Gastrointestinal Cancer
Mayo Clinic Cancer Center
Professor, Mayo Clinic College of Medicine and Science
Senior Associate Consultant
Division of Hematology and Oncology
Mayo Clinic 
Phoenix, Arizona 

Disclosure: Consultant: Amgen , Merck.

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Filter By